138 related articles for article (PubMed ID: 20059777)
1. Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy.
Petersen KD; Gyrd-Hansen D; Linneberg A; Dahl R; Larsen JN; Løwenstein H; Kronborg C
Int J Technol Assess Health Care; 2010 Jan; 26(1):20-9. PubMed ID: 20059777
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.
Erekosima N; Suarez-Cuervo C; Ramanathan M; Kim JM; Chelladurai Y; Segal JB; Lin SY
Laryngoscope; 2014 Mar; 124(3):616-27. PubMed ID: 23832632
[TBL] [Abstract][Full Text] [Related]
5. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
6. Utilization and cost of immunotherapy for allergic asthma and rhinitis.
Donahue JG; Greineder DK; Connor-Lacke L; Canning CF; Platt R
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):339-47. PubMed ID: 10227332
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires.
Petersen KD; Kronborg C; Gyrd-Hansen D; Dahl R; Larsen JN; Løwenstein H
Allergy; 2008 Mar; 63(3):284-91. PubMed ID: 18269674
[TBL] [Abstract][Full Text] [Related]
8. Patient initiation and persistence with allergen immunotherapy.
Anolik R; Schwartz AM; Sajjan S; Allen-Ramey F
Ann Allergy Asthma Immunol; 2014 Jul; 113(1):101-7. PubMed ID: 24814759
[TBL] [Abstract][Full Text] [Related]
9. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
Marogna M; Spadolini I; Massolo A
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
[TBL] [Abstract][Full Text] [Related]
10. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
11. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
[TBL] [Abstract][Full Text] [Related]
13. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
Pfaar O; Hörmann K; Klimek L
MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
[TBL] [Abstract][Full Text] [Related]
14. New visions in specific immunotherapy in children: an iPAC summary and future trends.
Halken S; Lau S; Valovirta E
Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
[TBL] [Abstract][Full Text] [Related]
15. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality.
Linneberg A; Jacobsen RK; Jespersen L; Abildstrøm SZ
J Allergy Clin Immunol; 2012 Feb; 129(2):413-9. PubMed ID: 22004944
[TBL] [Abstract][Full Text] [Related]
16. Identifying factors that affect patients' willingness to pay for inhaled insulin.
Pinto SL; Holiday-Goodman M; Black CD; Lesch D
Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
[TBL] [Abstract][Full Text] [Related]
17. Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis.
Aasbjerg K; Torp-Pedersen C; Backer V
Allergy; 2012 Nov; 67(11):1423-9. PubMed ID: 22984787
[TBL] [Abstract][Full Text] [Related]
18. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
19. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
20. The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting.
Smith AF; Pitt AD; Rodruiguez AE; Alio JL; Marti N; Teus M; Guillen S; Bataille L; Barnes JR
Ophthalmic Epidemiol; 2005 Aug; 12(4):233-42. PubMed ID: 16033744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
